AL3810
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AL3810, covering 2017-04-17 to 2020-02-05. Get the full timeline:
Most recent: Clinical Trial Update: This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients [Phase 2, Phase 3]